Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Highlights From Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Held In May 2018

    On May 18, 2018, the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) concluded two referrals for Zinbryta (daclizumab beta) and Esmya (ulipristal acetate) ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    NPPA Updates For The Month Of November On Price Capping Of Scheduled Formulations

    On November 23, 2017, National Pharmaceutical Pricing Authority (NPPA) has fixed/revised the retail price/ceiling price of 51 formulations of schedule-I formulations under Drug Price Control Order (DPCO), 2013.
    IndiaFood, Drugs, Healthcare, Life Sciences
S&A Law Offices
S&A Law Offices
  • Article

    Rajasthan High Court Orders FSSAI To Frame Regulations On Genetically Modified Foods, Citing Right To Safe Food Under Article 21

    In a decision with far-reaching implications for India's food safety regime, the Rajasthan High Court in Kritesh Oswal & Ors. v. Union of India & Ors. directed the Central Government...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Regulating Medical Practice: The Key Reforms Introduced By The Registered Medical Practitioner (Professional Conduct) Regulations, 2023

    On August 2, 2023 the National Medical Commission (NMC), Ethics and Medical Registration Board (EMRB) issued the Registered Medical Practitioner (Professional Conduct) Regulations, 2023 (Regulations) to regulate the practice and conduct of medical practitioners.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Economic Laws Practice
    Economic Laws Practice
  • Article

    TechRx: November 2023 Edition 2

    Court directs Indian government to frame policy for epharmacies: The High Court of Delhi has given the Indian government eight weeks to form a policy for online sale of medicines.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Ikigai Law
    Ikigai Law
  • Article

    The FSSAI Revolution 2026: From Periodic Renewal To Perpetual Validity

    For years, an FSSAI licence came bundled with a question every food business operator eventually had to answer: when does it expire, and when must it be renewed? In 2026, that question has fundamentally changed.
    IndiaFood, Drugs, Healthcare, Life Sciences
    LegaLogic
    LegaLogic
  • Article

    When Medicines Are Out Of Reach: Managed Access Programs For Unauthorized Medicines Or Treatments

    Before a new drug, biologic or medical device is approved and authorized for market launch, it has to undergo a long and complex process involving extensive testing and clinical trials...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Obhan Mason
    Obhan Mason
  • Article

    Domino's Secures Ex Parte Injunction Against Deceptively Similar Marks In Online Food Platforms

    In a recent ruling, the Delhi High Court granted an ex parte ad-interim injunction in favour of Dominos IP Holder LLC and Jubilant FoodWorks Limited, restraining multiple entities...
    IndiaIntellectual Property
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Foodlink F And B Holdings Private Limited v. Wow Momo Foods Private Limited 2023 SCC Online Del 4719

    The following article talks about the issues relating to the trademark of the section 29(2) of the Trade Marks Act which was creating confusion amongst the costumers...
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Patents And The Indian Pharmaceutical Industry

    It came under instrumental obligation to amend the patents law prevailing in the country, in order to make it compliant with the provisions of the international agreement.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Public Interest Rules Against Injunction Again

    Denial or grant of injunction in a patent infringement dispute in Indian courts or elsewhere on the ground of public interest is not a new trend.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Similar Trademark For Drug Treating The Same Ailment But Having Different Composition Deemed Deceptive By Bombay High Court

    In a significant ruling, the Bombay High Court, under Justice Firdosh P. Pooniwalla, declared that trademarks which are structurally and phonetically like an already registered mark cannot be registered for drugs...
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    A Legal Insight In To Foreign Investments In The Indian Food Processing Industry

    Food processing includes all the processes under filtration, manufacturing and preservation techniques undertaken for bringing value addition to the agricultural or horticultural produce.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Kochhar & Co.
    Kochhar & Co.
  • Article

    New Drugs And Clinical Trials Rules, 2019 – A Regulatory Overview

    Issues around payment of compensation in cases of clinical trial related injury, disability and death have long remained open. Despite a directive
    IndiaFood, Drugs, Healthcare, Life Sciences
    Cyril Amarchand Mangaldas
    Cyril Amarchand Mangaldas
  • Article

    Combination Therapies: Patentability Hitch!

    Recent trends in cancer chemotherapy treatments indicates that employing effective drug combinations in optimal doses are more effect.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Test For Determining Trademark Similarity For Nutraceutical Products Is The Same As The Test Applicable For Pharmaceutical

    In a suit for trademark infringement and passing off filed by Sun Pharma Laboratories Ltd. for its mark GLOEYE against Ajanta Pharma Ltd, which was using GLOTAB, the Delhi High Court held that principles laid down in Cadila ...
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Acquisition Of Uber Eats By Zomato – The Flaw In The Plan With Deep Discounting

    Yet another business gets hit by deep discounting! Clearly, this strategy can help penetrate and acquire market share only as long the wallet stretches.
    IndiaConsumer Protection
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Overcoming Pandemic Profiteering In Times Of Crisis

    Today, as the global scientific and research community doubles down on finding a potential drug or vaccine against the novel Coronavirus, the obvious question that arises is of access
    IndiaCoronavirus (COVID-19)
    Obhan Mason
    Obhan Mason
  • Article

    CDSCO Notice Regarding Strict Regulatory Control Over Manufacture, Sale And Distribution Of Oxytocin And To Curb Its Misuse

    Oxytocin, a neuro-hormone that also acts as neurotransmitter in brain, is naturally released in large amounts by the posterior pituitary gland in mammals.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Centralising Religious Dietary Certifications: An Analysis Of The Food Safety And Standards (Amendment) Bill, 2025

    The introduction of the Food Safety and Standards (Amendment) Bill, 2025 marks a decisive shift in India's regulatory approach towards faith-based and religious dietary certifications...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Showing 581–600 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics